Mental Health Drugs and Their Impact on Society
In each country, the number of people under mental health drugs is high and has been rapidly increasing over the past few years (WHO, 14). When prescribed mental health drugs are cheaper and highly available to everyone, then the economic value of the country will be deteriorated. Insurance companies have laid it bare that it's not possible to access the prescribed mental drugs that easily but they have to follow all necessary bureaucracies. Although the medications are prescribed and are diagnosed by health providers, it is possible to misuse such drugs. The mental disorder condition has many preventive measures than the curative drugs so the drugs will not serve for the better of the community, but will increase the population affected. There should be better programs and awareness clearance forums to avoid mental disorders.
The Economic Impact of Mental Health Drugs
Drug companies have their objectives and goals that have to attain at the end of their year so when they offer the drugs at a lower price means that they will undergo huge financial losses. To avoid these losses, the price of mental drugs must be maintained. For patients to value the drugs, they must cost them some percentage. The government and any other drug company should manage their processes.
Addressing Mental Health Issues in Different Communities
A systematic review of various medical articles and also the first-hand information I have received from the field is enough information to provide all the necessary information. In some communities especially the lower social level, there has been cheaper medication whereas there is no insurance cover needed yet the number has continued to increase and high level of drug misuse (Wahlbeck, Kristian, et al, 455). Pharmaceuticals companies and other drug industries can offer drugs randomly. This will have a more positive contribution than having a systematic approach of providing medical cover.
Work cited
Wahlbeck, Kristian, et al. "Outcomes of Nordic mental health systems: life expectancy of patients with mental disorders." The British Journal of Psychiatry 199.6 (2011): 453-458.
World Health Organization. Department of Mental Health, et al. Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. World Health Organization, (2009): 14
